Publications found:
221
Sort by:
Biologics Contract Research Organizations Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, And Clinical), By Product (Vaccines, Cell & Gene Therapies), By Service, By Therapeutic Area, By End Use, By Region, and Segment Forecasts, 2026 - 2033
US$ 5,950.00
Biologics Contract Research Organizations Market The global biologics contract research organizations market size was estimated at USD 14.88 billion in 2025 and is projected to reach USD 32.30 billion...
May 2026
150 pages
Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule (Small, Large), By Test (ADME, PD, PK, Bioavailability, Bioequivalence, Biomarker Testing, Cell-based Assay), By Workflow, By End Use, By Region, and Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global bioanalytical testing services market size is anticipated to reach USD 4.83 billion by 2026, according to a new report by Grand ... of pharmaceutical products. The rising consumption is projected to drive the bioanalytical testing services market over the forecast period. Further key findings from the ...
May 2026
150 pages
Pharmaceutical Isolators Market Size, Share & Trends Analysis Report By Type (Open Isolator, Closed Isolator), By Product (Positive Pressure, Negative Pressure), By Region (North America, Asia Pacific, Europe, Latin America, MEA), And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Pharmaceutical Isolators Market The global pharmaceutical Isolators market size was estimated at USD 802.4 million in 2025 and is projected to reach USD 1,552.0 million by 2033, growing at a CAGR of 8...
May 2026
100 pages
Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Type (Topical, Transdermal, Oral), By Product (Creams, Gels, Ointments, Pastes), By End Use (Pharmaceutical Companies), By Company Size, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Semi-solid Dosage Contract Manufacturing Market The global semi-solid dosage contract manufacturing market size was estimated at USD 21.21 billion in 2025, and is projected to reach USD 50.36 billion...
May 2026
120 pages
Botulinum Toxin CDMO Market Size, Share & Trends Analysis Report By Product (Type A Botulinum Toxin, Type B Botulinum Toxin), By Service (Packaging & Labelling, Regulatory Affairs, Supply Chain & Logistics), By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Botulinum Toxin CDMO Market The global botulinum toxin CDMO market size was estimated at USD 2.5 billion in 2025 and is projected to reach USD 5.8 billion by 2033, growing at a CAGR of 11.5% from 2026...
May 2026
120 pages
Viral Vector Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Test (Titer & Quantification Testing, Safety Testing, Purity & Impurity Analysis), By Viral Vector (Lentiviral Vectors, AAV), By Development Stage (Preclinical, Clinical), By End-use, By Region, and Segment Forecasts, 2026 - 2033
US$ 5,950.00
Viral Vector Bioanalytical Testing Services Market The global viral vector bioanalytical testing services market size was estimated at USD 578.5 million in 2025 and is projected to reach USD 1,155.7 m...
May 2026
150 pages
Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Tablets, Capsules, Powders, Granules), By Mechanism (Controlled Release, Immediate Release), By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Oral Solid Dosage Contract Manufacturing Market The global oral solid dosage contract manufacturing market size was valued at USD 10.20 billion in 2025 and is projected to reach USD 21.25 billion by 2...
May 2026
150 pages
Sterile Injectable Contract Manufacturing Market Size, Share & Trends Analysis Report By Molecule (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route of Administration, By End Use, By Region, and Segment Forecasts, 2026 - 2033
US$ 5,950.00
Sterile Injectable Contract Manufacturing Market The global sterile injectable contract manufacturing market size was estimated at USD 24.5 billion in 2025 and is projected to reach USD 57.2 billion b...
May 2026
150 pages
Global Biopharmaceutical CDMO Market Size Study and Forecast by Type (API, Finished Drug Product), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Gene Therapy Products, Cell Therapy Products, Others), Service (Process Development, Analytical Testing, Manufacturing Services, Fill-Finish Services, Packaging & Labeling), Source (Mammalian Cells, Microbial Systems, Yeast Systems, Insect Cells, Others), Workflow (Upstream Processing, Downstream Processing, Fill-Finish Operations), Therapeutic Area (Oncology, Infectious Diseases, Autoimmune Disorders, Cardiovascular Diseases, Neurological Disorders, Others), End Use (Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Others), and Regional Forecasts 2026-2035
US$ 3,750.00
The global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO) market encompasses third-party service providers that support biotechnology and pharmaceutical companies in the...
April 2026
285 pages
Asia Pacific Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The Asia Pacific Biopharmaceutical Contract Manufacturing Market is poised for remarkable growth, projected to reach approximately US$ 26,544.2 million by 2031, up from US$ 10,448.9 million in 2024. T...
March 2026
176 pages
Europe Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The Europe Biopharmaceutical Contract Manufacturing Market is projected to grow significantly, reaching an estimated US$ 27,678.2 million by 2031, up from US$ 11,420.5 million in 2024. This growth ref...
March 2026
177 pages
Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The Middle East & Africa Biopharmaceutical Contract Manufacturing Market is poised for significant growth, with projections indicating an increase from US$ 875.4 million in 2024 to US$ 1,655.0 million...
March 2026
168 pages
North America Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The North America Biopharmaceutical Contract Manufacturing Market is poised for significant growth, with projections indicating it will reach approximately US$ 41,018.6 million by 2031, up from US$ 16...
March 2026
162 pages
South & Central America Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The South & Central America Biopharmaceutical Contract Manufacturing Market is poised for significant growth, with projections indicating an increase from US$ 1,766.4 million in 2024 to US$ 4,155.6 mi...
March 2026
168 pages
